VIIV HEALTHCARE

Lobbying client · North Carolina · filed 2025 to 2026

Biopharmaceutical company focused on HIV prevention and treatment

$145,000 Reported spend

6 Filings counted

1 Firms hired

0 Bills named

Spend is reported income plus in-house expenses across 6 filings. 1 further filing on this record was restated by a later amendment and is left out of every total here. Everything on this page is grouped by the client's LDA id (66695), not by name.

Firms hired 1

DGA GROUP GOVERNMENT RELATIONS LLC $145,000 6 filings

Reported by year 2 years

2026 $15,000 2 filings
2025 $130,000 4 filings

Issues lobbied 1

Trade (domestic/foreign) 5

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 3

HOUSE OF REPRESENTATIVES 4
SENATE 4
U.S. Trade Representative (USTR) 4

Recent filings 7 total

1A

DGA GROUP GOVERNMENT RELATIONS LLC

1st Quarter (Jan 1 - Mar 31) 2026 · House · Senate · $15,000 income · posted Jul 29, 2026

View → Q2Y

DGA GROUP GOVERNMENT RELATIONS LLC

2nd Quarter (Apr 1 - June 30) 2026 · posted Jul 16, 2026

View → Q1

DGA GROUP GOVERNMENT RELATIONS LLC Amended

1st Quarter (Jan 1 - Mar 31) 2026 · House · Senate · $10,000 income · posted Apr 16, 2026

View → Q4

DGA GROUP GOVERNMENT RELATIONS LLC

4th Quarter (Oct 1 - Dec 31) 2025 · House · Senate · $10,000 income · posted Jan 15, 2026

View → Q3

DGA GROUP GOVERNMENT RELATIONS LLC

3rd Quarter (July 1 - Sep 30) 2025 · House · Senate · $60,000 income · posted Oct 20, 2025

View → Q2

DGA GROUP GOVERNMENT RELATIONS LLC

2nd Quarter (Apr 1 - June 30) 2025 · House · Senate · $60,000 income · posted Jul 22, 2025

View → RA

DGA GROUP GOVERNMENT RELATIONS LLC

2nd Quarter (Apr 1 - June 30) 2025 · posted Jun 16, 2025

View →

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.